Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VAMOROLONE vs VASOPRESSIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VAMOROLONE vs VASOPRESSIN: Safety Overview

Metric VAMOROLONE VASOPRESSIN
Total FAERS Reports 941 1,953
Deaths Reported 15 801
Death Rate 1.6% 41.0%
Hospitalizations 96 1,195
Average Patient Age 11.9 yrs 60.6 yrs
% Female Patients 1.9% 27.2%
FDA Approval Date Oct 26, 2023 Approved Prior to Jan 1, 1982
Manufacturer Catalyst Pharmaceuticals, Inc. Sagent Pharmaceuticals
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued